Defective CP does not oxidise Fe2+ to Fe3+

Stable Identifier
R-HSA-5621402
Type
Reaction [transition]
Species
Homo sapiens
Compartment
extracellular region, plasma membrane
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Defective CP does not oxidise Fe2+ to Fe3+
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Ceruloplasmin (CP), synthesised in the liver and secreted into plasma, is a copper-binding (6-7 atoms per molecule) glycoprotein involved in iron trafficking in vertebrates. CP is essential for SLC40A1 (ferroportin) stability at the cell surface, the protein that mediates iron efflux from cells. CP also possesses ferroxidase activity, which oxidises ferrous iron (Fe2+) to ferric iron (Fe3+) following its transfer out of the cell. Defects in CP (or indeed SLC40A1) can lead to the phenotype of iron overload as seen in the disorder aceruloplasminemia (ACERULOP; MIM:604290). It is a rare autosomal recessive disorder of iron metabolism characterised by iron accumulation mainly in the brain, but also in liver, pancreas and retina. Patients develop retinal degeneration, diabetes mellitus and neurological disturbance.

Mutations that can cause ACERULOP include W858*, E797Rfs*12, D411Tfs*36 and 778fs*12 (Takahashi et al. 1996, Logan et al. 1994, Okamoto et al. 1996, Harris et al. 1995).
Literature References
PubMed ID Title Journal Year
8641692 Hereditary ceruloplasmin deficiency with hemosiderosis

Kawabata, Y, Okamoto, N, Takeda, Z, Wada, Y, Wada, S, Oga, T, Habu, D, Baba, Y

Hum. Genet. 1996
8789443 Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease

Suenaga, A, Shirabe, S, Gitlin, JD, Takahashi, Y, Nagataki, S, Miyajima, H

Hum. Mol. Genet. 1996
7708681 Aceruloplasminemia: molecular characterization of this disorder of iron metabolism

Gitlin, JD, Takahashi, Y, Serizawa, M, Harris, ZL, MacGillivray, RT, Miyajima, H

Proc. Natl. Acad. Sci. U.S.A. 1995
7820540 Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus

Hughes, AE, Wisdom, GB, Archbold, GP, Harveyson, KB, Logan, JI

QJM 1994
Participants
Input
Participates
as an event of
Catalyst Activity

ferroxidase activity of CP mutants:6xCu2+:SLC40A1 [plasma membrane]

Physical Entity
CP mutants:6xCu2+:SLC40A1 [plasma membrane] (Homo sapiens)
Activity
ferroxidase activity (GO:0004322)
Normal reaction
SLC40A1:CP:6Cu2+ oxidises Fe2+ to Fe3+ (Homo sapiens)
Functional status

Loss of function of CP mutants:6xCu2+:SLC40A1 [plasma membrane]

Normal Entity
Disease Entity
Status
Disease
Name Identifier Synonyms
aceruloplasminemia DOID:0050711
Authored
Jassal, B  (2014-08-29)
Reviewed
Broer, S  (2015-08-04)
Created
Jassal, B  (2014-08-29)
Cite Us!